ADARx Pharmaceuticals, Inc. (NASDAQ:ADRX) IPO

ADARx Pharmaceuticals, Inc.

IPO

Priced at US$17.00 a share on Sep 24, 2026.

Price
US$17.00 a share
Shares offered
26,250,000 shares of common stock
Offering size
US$446.3 million
Underwriters' option
Up to 3,937,500 more shares
Listing
ADRX on the Nasdaq Global Select Market
Underwriters
J.P. Morgan, Morgan Stanley, TD Cowen, UBS Investment Bank, LifeSci Capital · In the order on the cover
Shares delivered
On or about Sep 28, 2026

Steps

StepWhen
Draft sent to the SEC in confidenceJun 22, 2026
Filed publiclySep 4, 2026
Amended twiceNewest Sep 21, 2026
Shares registered with an exchangeSep 22, 2026
Declared effective by the SECSep 24, 2026
Final prospectus, with the priceSep 28, 2026

From the cover of the final prospectus (424B4) filed Sep 28, 2026